Infliximab Intravenous Products Preferred Specialty Management Policy
Customize your policy alerts
Sign up for Cigna Policy PSM005 alerts
Get alerted when Policy PSM005 changes without checking for updates manually.
Monitor payer policy activity
Cigna's preferred specialty management program that governs prior authorization and preferred product sequencing for infliximab intravenous products for members covered by Cigna-administered health benefit plans.
No material clinical or coverage changes in this revision.
Coverage Criteria for Infliximab Intravenous Products
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.